$28.20 -0.67 (-2.32%) Genomic Health Inc - NASDAQ

Jul. 22, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 28.20
Trade Time: Jul 22 04:00 PM Eastern Daylight Time
Change: -0.67 (-2.32%)
Prev Close: 28.87
Open: 28.81
Bid: 28.18
Ask: 28.20
  1. Mid-Morning Market Update: Markets Open Higher; Time Warner Posts Mixed Q4 Results

    Benzinga | Feb. 10, 2016 | 09:49AM EST
  2. Benzinga's Top #PreMarket Losers

    Benzinga | Jan. 8, 2016 | 08:20AM EST
  3. Benzinga's Top Upgrades

    Benzinga | Nov. 23, 2015 | 08:56AM EST
  4. Morning Market Gainers

    Benzinga | Nov. 4, 2015 | 09:50AM EST
  5. CMS Increases Final Pricing Determination for Oncotype DX Breast Cancer Test to Previously Established Rate of $3,416

    Benzinga | Oct. 7, 2015 | 08:09AM EST
  6. A Portfolio To Support Cancer Treatments In Time For Prostate Cancer Awareness Month

    Benzinga | Sep. 8, 2015 | 16:05PM EST
  7. Genomic Health's Oncotype DX® Prostate Cancer Test Receives Medicare Coverage

    Benzinga | Aug. 17, 2015 | 08:06AM EST
  8. Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto GBA on Medicare Coverage for the Oncotype DX Prostate Cancer Test

    Benzinga | May. 21, 2015 | 08:25AM EST
  9. Oncotype DX® DCIS Score™ Represents Breakthrough in Personalizing Treatment of Pre-Invasive Breast Cancer

    Benzinga | Dec. 12, 2014 | 08:31AM EST
  10. Oncotype DX Predicts Outcomes In Prostate Cancer Patients, Significantly Changes Treatment Recommendations

    Benzinga | Dec. 3, 2014 | 08:03AM EST
  11. Genomic Health Reports Positive Results from Latest Clinical Validation Study of Oncotype DX

    Benzinga | Sep. 29, 2014 | 08:06AM EST
  12. Upcoming Corporate Events/Presentations for the Week of Aug. 11-15th

    Benzinga | Aug. 11, 2014 | 11:54AM EST
  13. UPDATE: Bank of America Reiterates on Genomic Health as 2014 Outlook is Below Expectations

    Benzinga | Feb. 5, 2014 | 10:14AM EST
  14. UPDATE: Bank of America Downgrades Genomic Health on Lack of Near-Term Catalysts, Limited Upside

    Benzinga | Oct. 1, 2013 | 08:54AM EST
  15. Genomic Health Presents Four Oncotype DX Studies for Breast and Colon Cancer at ECC 2013

    Benzinga | Oct. 1, 2013 | 05:52AM EST
Trading Center